miR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancerDongli Zhao, Xiaoqiang Zheng|Oncology Reports|2015Cited by 84
<p>PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer</p>Xiao Fu, Yu Yao, Luochengling Xiang et al.|Cancer Management and Research|2020Cited by 14